Open AccessEffect of Citalopram in Combination with Omega-3 on Depression in Post- menopausal Women: A Triple Blind Randomized Controlled Trial
Author(s) -
Seyedeh Zahra Masoumi,
Farideh Kazemi,
Samira Tavakolian,
Alireza Rahimi,
Khodayar Oshvandi,
Ali Reza Soltanian
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/19487.8597
Subject(s) - citalopram , depression (economics) , randomized controlled trial , sertraline , antidepressant , medicine , major depressive disorder , placebo , psychiatry , psychology , mood , anxiety , alternative medicine , pathology , economics , macroeconomics
Depressive disorder is a common and disabling disorder that causes high rates of morbidity and mortality. Citalopram is an antidepressant drug, of the Selective Serotonin Reuptake Inhibitor (SSRI) class that has been used for geriatric depression since a long time ago. Prescription of omega-3 in geriatric depression has been increased recently; because of more favorable profile of their side effects. Some of the studies reported that omega-3 is effective in prevention or treatment of depressive disorders than Citalopram. However, there are contradictory studies too.